These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5975771)

  • 1. Ovulen as an oral contraceptive.
    Banner EA
    J Lancet; 1966 Sep; 86(9):463-5 passim. PubMed ID: 5975771
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study with 1 mg of ethynodiol diacetate and 0.1 mg (1.0-0.1) mestranol].
    Mateos Candano M; Bolio Arista R
    Ginecol Obstet Mex; 1967; 22(127):151-61. PubMed ID: 5604500
    [No Abstract]   [Full Text] [Related]  

  • 3. Enzyme histochemical studies on the endometrium in Ceylonese. Including investigation of enzymic alterations developing in the endometrium following treatment with the oral contraceptive "ovulen".
    Panabokke RG; Nelson AD; Fernando WH; Jayaweera B; Gunatilleka DE
    Ceylon Med J; 1971 Sep; 16(3):141-56. PubMed ID: 5149420
    [No Abstract]   [Full Text] [Related]  

  • 4. [Investigations of the cervical factor in the treatment with Ovulen].
    Odeblad E
    Lakartidningen; 1967 Jul; 64(29):2903-6. PubMed ID: 5597595
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of ethynodiol diacetate and mestranol on blood glucose and plasma insulin. I. Six month oral glucose tolerance test.
    Spellacy WN; Buhi WC; Birk SA; McCreary SA
    Int J Fertil; 1971; 16(2):55-65. PubMed ID: 5092534
    [No Abstract]   [Full Text] [Related]  

  • 6. [Temporary control of fertility with ethynodiol diacetate and mestranol (1.0/0.1) in women with a high obstetrical risk. Study of 2400 cycles].
    Alvarado Duran A; Lopez Llera M; Carbia Aguilar E
    Ginecol Obstet Mex; 1968 Feb; 23(136):291-300. PubMed ID: 5681098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ovulen, its effect on the endometrium, uterine cervix and ovary].
    Muller G; Dehalleux JM; Ritter J; Philippe E; Gandar R
    Gynecol Obstet (Paris); 1968; 67(5):521-32. PubMed ID: 5730661
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma lipid and lipoprotein alterations during oral contraceptive administration.
    Sachs BA; Wolfman L; Herzig N
    Obstet Gynecol; 1969 Oct; 34(4):530-5. PubMed ID: 5822679
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of a new low-dosage oral contraceptive pill on lactation.
    Ibrahim A; el-Tawil NZ
    Int Surg; 1968 Jun; 49(6):561-5. PubMed ID: 5657251
    [No Abstract]   [Full Text] [Related]  

  • 10. A andomized contraceptive trial comparing a daily progestogen with a combined oral contraceptive steroid.
    Paulsen ML; Varaday A; Brown BW; Kalman SM
    Contraception; 1974 May; 9(5):497-506. PubMed ID: 4448081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma insulin responses to glucose in normal and subclinical diabetic women treated with oral contraceptive agents.
    Beck P; Wells SA
    Diabetes; 1968; 17():307-8. PubMed ID: 5689961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Estrogen contents and progestagenic activity of 2 compounds containing ethynodiol diacetate].
    Jedrzejewski M; Krzywdziński K; Teter J
    Endokrynol Pol; 1972; 23(6):538-7. PubMed ID: 4680323
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrocarbons in human cervical mucus and the effect of oral contraception.
    Singh EJ; Swartwout JR; Boss S
    J Reprod Med; 1972 Mar; 8(3):128-32. PubMed ID: 4113025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Action of a contraceptive (ovulene) on mouse mammary carcinogenesis].
    Coezy E; Rudali G
    Rev Eur Etud Clin Biol; 1970 Feb; 15(2):205-9. PubMed ID: 5462688
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal study of the effects of oral contraceptives on human chromosomes.
    de Gutiérrez AC; Lisker R
    Ann Genet; 1973 Dec; 16(4):259-62. PubMed ID: 4544089
    [No Abstract]   [Full Text] [Related]  

  • 16. Electrophoretic study of serum proteins in women using oral contraceptive for 1 to 3 years.
    Gupta P; Sharma PK; Saxena SB; Garg S; Nath S
    J Obstet Gynaecol India; 1973 Apr; 23(2):148-51. PubMed ID: 4806731
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of 19-norsteroids on the motility of human fallopian tubes.
    Jakobovits A; Gecse A; Piukovich I; Szontágh F; Karády I
    Int J Fertil; 1970; 15(1):36-9. PubMed ID: 5416878
    [No Abstract]   [Full Text] [Related]  

  • 18. [EXPERIENCE WITH OVULEN, A NEW OVULATION INHIBITOR].
    BAUNACH A; BAUNACH M
    Med Welt; 1964 Oct; 41():2207-11. PubMed ID: 14334333
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of oral contraceptives on lipoprotein lipids: a prospective study.
    Powell MG; Hedlin AM; Cerskus I; Kakis G; Prudham D; Rosenrot P
    Obstet Gynecol; 1984 Jun; 63(6):764-70. PubMed ID: 6427714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical aspects of Ovulen application as a contraceptive and in gynecological disorders].
    Bulska M; Sternadel Z; Pietrusiewicz W
    Ginekol Pol; 1970; 41(8):877-82. PubMed ID: 5459598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.